Autism therapies

Autism Learning Partners Opens Its 3rd Location in New York to Serve the Yonkers Community

Retrieved on: 
Thursday, July 29, 2021
Autism therapies, Treatment of autism, Yonkers, New York

YONKERS, N.Y., July 29, 2021 /PRNewswire-PRWeb/ --Autism Learning Partners (ALP), a national leader that specializes in the treatment of autism and other developmental disabilities, is pleased to announce its in-state expansion with the addition of the Yonkers, New York location.

Key Points: 
  • YONKERS, N.Y., July 29, 2021 /PRNewswire-PRWeb/ --Autism Learning Partners (ALP), a national leader that specializes in the treatment of autism and other developmental disabilities, is pleased to announce its in-state expansion with the addition of the Yonkers, New York location.
  • The Yonkers location will join the existing three offices effectively serving the state.
  • ALP is committed to continuing its collaborative efforts with other service providers in the Yonkers area to ensure consistency of care.
  • To learn more about Autism Learning Partners and its services, please visit AutismLearningPartners.com.

Receptor Life Sciences Announces Initiation of IND-Opening Clinical PK Study of RLS102 for Irritability in Autism Spectrum Disorder

Retrieved on: 
Monday, July 19, 2021
Health, FDA, Clinical trials, Research, Science, Pharmaceutical, Biotechnology, Branches of biology, Psychiatric diagnosis, Psychiatry, Neuroscience, Autism, Developmental neuroscience, Developmental psychology, Learning disabilities, Autism spectrum, Irritability, Developmental disorder, Autism therapies

This first-in-class, pure synthetic CBD capsule is being investigated for the treatment of irritability in patients with autism spectrum disorder.

Key Points: 
  • This first-in-class, pure synthetic CBD capsule is being investigated for the treatment of irritability in patients with autism spectrum disorder.
  • Following the IND acceptance, RLS initiated a pharmacokinetic (PK), formulation selection study using RLS102 in healthy volunteers.
  • RLS102 has the potential to be a new treatment to reduce irritability in patients living with autism spectrum disorder, said Mark Theeuwes, President and CEO, Receptor Life Sciences.
  • A complex developmental disorder often associated with a high level of irritability, autism spectrum disorder (ASD) affects about 5 million adults in the United States ( https://www.cdc.gov/ncbddd/autism/features/adults-living-with-autism-spe... ).

Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel™ in Children and Adolescents with Both Developmental and Epileptic Encephalopathies (DEE) and Autism Spectrum Disorder (ASD) at the Associated Professional Sleep Societies SLEEP 2021 Annual

Retrieved on: 
Friday, June 11, 2021
Branches of biology, Psychiatry, Psychiatric diagnosis, Abnormal psychology, Autism, Pervasive developmental disorders, Developmental neuroscience, Developmental psychology, Autism spectrum, Conditions comorbid to autism spectrum disorders, Autism therapies

Furthermore, the children with both DEE and autism spectrum disorder (ASD) showed more wide-ranging benefits on sleep compared to those with DEE alone.

Key Points: 
  • Furthermore, the children with both DEE and autism spectrum disorder (ASD) showed more wide-ranging benefits on sleep compared to those with DEE alone.
  • Epilepsy and sleep disorders have a bidirectional relationship and co-occur in individuals with ASD.
  • While these results are exploratory in nature, they are encouraging and warrant confirmation in future clinical trials of Zygel in patients with DEE and/or ASD.
  • Any forward-looking statements that the Company makes in this press release speak only as of the date of this press release.

New England ABA Selected to Partner with Massachusetts Child Psychiatry Access Program for Autism Spectrum Disorder-Intellectual Disability (MCPAP for ASD-ID) Consultation Services

Retrieved on: 
Wednesday, April 28, 2021
Psychology, Mind, Self, Psychiatric diagnosis, Behaviorism, Autism, Applied behavior analysis, Child and adolescent psychiatry, Autism spectrum, Autism therapies

Having our BCBAs as a resource will help those with ASD-ID navigate crises safely with the goal of keeping families together.

Key Points: 
  • Having our BCBAs as a resource will help those with ASD-ID navigate crises safely with the goal of keeping families together.
  • To date, 38 states, Washington, DC, and British Columbia, struggling with similar and even more severe access issues, have developed child psychiatry consultation programs based on the MCPAP model.
  • For more information about MCPAP, visit www.mcpap.com .\nFounded in 2015, New England ABA, Inc. has been providing home and community-based Applied Behavior Analysis (ABA) therapy services to children and adolescents with Autism.
  • The Stepping Stones Group is a leading provider of therapeutic and behavioral services to children including those with special needs and autism.

The Place for Children with Autism Announces Allison O'Neill as Chief Executive Officer

Retrieved on: 
Monday, March 22, 2021
Psychology, Mind, Articles, Treatment of autism, Psychiatric diagnosis, Autism therapies, Autism, Applied behavior analysis, Draft:Hopebridge Autism Therapy Centers, Draft:Healis Autism Centre

CHICAGO, March 22, 2021 /PRNewswire/ --The Place for Children with Autism ("The Place"), a leading provider of applied behavior analysis therapy services for children with autism , announces that Allison O'Neill has been named Chief Executive Officer of the rapidly growing healthcare services provider.

Key Points: 
  • CHICAGO, March 22, 2021 /PRNewswire/ --The Place for Children with Autism ("The Place"), a leading provider of applied behavior analysis therapy services for children with autism , announces that Allison O'Neill has been named Chief Executive Officer of the rapidly growing healthcare services provider.
  • Most recently, Allison served as the President and Chief Operating Officer of ChanceLight Behavioral Health, Therapy and Education.
  • "When I founded The Place for Children with Autism, I believed that we could truly change the face of autism therapy treatment in this country through unmatched clinical quality and compassionate care," said The Place Founder and Executive Chairman Daniel Blank.
  • The Place for Children with Autism specializes in providing the highest quality autism therapy (i.e., applied behavior analysis: ABA therapy) in a preschool-like setting for children with autism ages 2-6.

NIH research delivers promising results for non-verbal children with autism using Video-Assisted Speech Therapy (VAST)

Retrieved on: 
Thursday, March 18, 2021
Autism, Branches of biology, Psychiatric diagnosis, Abnormal psychology, Psychiatry, Pervasive developmental disorders, Autism spectrum, Developmental neuroscience, Virtual reality, Draft:Healis Autism Centre, Autism therapies

The research project measured the impact of iTherapy's Video-Assisted Speech Therapy Software on functional language abilities in non- and minimally verbal children with autism spectrum disorder (ASD).

Key Points: 
  • The research project measured the impact of iTherapy's Video-Assisted Speech Therapy Software on functional language abilities in non- and minimally verbal children with autism spectrum disorder (ASD).
  • iTherapy, LLC Bay Area developers of immersive educational technology for those with communication challenges, such as autism today announced exciting results from a Phase I NIH-funded research project.
  • Results showed measurable positive changes in the areas of imitation, accuracy, joint attention, and social referencing, after just seven weeks.
  • All participating children completed a three-minute VAST session, twice a week either on a tablet or using a virtual-reality (VR) headset.

Quality Autism Therapy, Now Accessible at Multiple Colorado Locations

Retrieved on: 
Friday, February 26, 2021
Psychology, Mind, Psychiatric diagnosis, Branches of biology, Autism, Developmental neuroscience, Developmental psychology, Behaviorism, Autism spectrum, Applied behavior analysis, Draft:Hopebridge Autism Therapy Centers, Autism therapies

The company recently completed its 20th year in business, and has over 55 centers across Texas, Oklahoma, and Colorado.

Key Points: 
  • The company recently completed its 20th year in business, and has over 55 centers across Texas, Oklahoma, and Colorado.
  • ABA therapy is a science-based discipline that helps manage behavioral conditions brought on by Autism Spectrum Disorder (ASD).
  • Behavioral Innovations is a trailblazer in delivering 1-to-1 personalized treatment plans, which ensures undivided attention to the kids when they enroll at one of their locations.
  • People can follow them on Facebook and Instagram to receive regular updates on ABA Therapy and autism resources.

Hopebridge plans to hire 2,700 employees in 2021

Retrieved on: 
Tuesday, January 12, 2021
Health sciences, Treatment of autism, Psychiatric diagnosis, Life sciences, Health, Autism therapies, Autism, Therapy

INDIANAPOLIS, Jan. 12, 2021 (GLOBE NEWSWIRE) -- One of the largest autism therapy healthcare providers in the nation, Hopebridge Autism Therapy Centers, plans to hire more than 2,700 employees in 2021 to meet the growing need for ABA therapy in six states: Arizona, Colorado, Indiana, Georgia, Kentucky and Ohio.

Key Points: 
  • INDIANAPOLIS, Jan. 12, 2021 (GLOBE NEWSWIRE) -- One of the largest autism therapy healthcare providers in the nation, Hopebridge Autism Therapy Centers, plans to hire more than 2,700 employees in 2021 to meet the growing need for ABA therapy in six states: Arizona, Colorado, Indiana, Georgia, Kentucky and Ohio.
  • The company also plans to add up to 20 additional locations within the next 12 months, starting with three Colorado locations in January 2021.
  • Each hire ensures that every child at Hopebridge receives the one-on-one therapy they deserve.
  • The expansion will also make Hopebridges unique, interdisciplinary approach to autism therapy, Hopebridge 360Care , more accessible to families and children in the states Hopebridge serves.

Hopebridge Expands Leadership Team, Adds Dr. Adam Hahs

Retrieved on: 
Monday, January 11, 2021
Health, Clinical officer, Autism therapies, Autism, Branches of biology

INDIANAPOLIS, Jan. 11, 2021 (GLOBE NEWSWIRE) -- One of the largest autism therapy healthcare providers in the nation, Hopebridge Autism Therapy Centers, announced today the addition of Dr. Adam Hahs to the companys leadership team.

Key Points: 
  • INDIANAPOLIS, Jan. 11, 2021 (GLOBE NEWSWIRE) -- One of the largest autism therapy healthcare providers in the nation, Hopebridge Autism Therapy Centers, announced today the addition of Dr. Adam Hahs to the companys leadership team.
  • Serving as vice president of clinical services, Dr. Hahs will be responsible for leading the clinical leadership team, continuing to enhance its leading quality of care, and helping to drive research initiatives.
  • We continue to make investments in our leading clinical quality of care, said Hopebridge Founder & Chief Clinical Officer Kim Strunk.
  • I am thrilled to be joining the Hopebridge team with the unified mission of bettering the lives of children with autism, said Dr. Hahs.

United States Autism Treatment Market Report 2020: A Fragmented $2.1 Billion Market - Forecast to 2025

Retrieved on: 
Wednesday, December 23, 2020
Psychiatric diagnosis, Autism, Branches of biology, Psychiatry, Abnormal psychology, Learning disabilities, Neurological disorders, Pervasive developmental disorders, Autism therapies, Low-functioning autism

DUBLIN, Dec. 23, 2020 /PRNewswire/ -- The "The U.S. Autism Treatment Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 23, 2020 /PRNewswire/ -- The "The U.S. Autism Treatment Market" report has been added to ResearchAndMarkets.com's offering.
  • This is a fragmented $2.1 billion market comprised of for-profit and non-profit providers that serve autistic patients via brick & mortar centers and in-home therapy provided by therapists.
  • The incidence of autism among American children has soared from 1 in 150 in 2000 to 1 in 54 today, and 3.5 million children and adults now live with autism.
  • Yet, few therapies exist to treat this disease - just a few medications and ABA (applied behavioral analysis) programs.